Featured Research

from universities, journals, and other organizations

High risk of cardiovascular diseases amongst Swedish-born and immigrant MS patients

Date:
February 4, 2013
Source:
Karolinska Institutet
Summary:
A new study from Sweden shows that patients with multiple sclerosis (MS) run a high risk of heart attack, stroke and heart failure, regardless of migration background. The study is the first in the world to examine the risk of cardiovascular diseases in male and female MS patients with both non-immigrant and immigrant backgrounds.

A new study from Karolinska Institutet in Sweden shows that patients with multiple sclerosis (MS) run a high risk of heart attack, stroke and heart failure, regardless of migration background. According to Dr Tahereh Moradi, principal investigator, the study is the first in the world to examine the risk of cardiovascular diseases in male and female MS patients with both non-immigrant and immigrant backgrounds.

MS is a chronic inflammatory disease that breaks down the central nervous system, and is the most common neurological cause of disability amongst young people. The study now published in the scientific periodical Multiple Sclerosis Journal examined over 8,000 MS patients between the years 1987 and 2009.

"It turns out that MS patients run a 85 per cent higher risk of myocardial infarction, a 70 per cent higher risk of stroke, and a 100 per cent higher risk of heart failure, results that are consistent in both young and elderly patients, and patients born in and outside Sweden, with the effect being particularly noticeable for women," says principal investigator Dr Tahereh Moradi, Associate Professor at Karolinska Institutet's Institute of Environmental Medicine.

With MS striking two in every 10,000 people, primarily women, every year, Sweden has one of the highest rates of the disease in the world. Despite the rising incidence of MS across the globe, its etiology is still unknown.

"These kinds of study have important public health and clinical implications," says Dr Moradi. "They can help us to understand the causes of MS and whether they resemble those of cardiovascular diseases. The results indicate how important it is that preventative measures against cardiovascular diseases are taken with MS patients, and that these patients, particularly the women, are kept under regular and careful observation."

The study was a joint initiative by Karolinska Institutet and Healthcare Provision, Stockholm County, and was conducted using the Migration and Health database, which is based on around a dozen national registers and designed for the study of diseases amongst socially disadvantaged groups, immigrants and children of immigrants in Sweden.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Jadidi, M. Mohammadi, T. Moradi. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Multiple Sclerosis Journal, 2013; DOI: 10.1177/1352458513475833

Cite This Page:

Karolinska Institutet. "High risk of cardiovascular diseases amongst Swedish-born and immigrant MS patients." ScienceDaily. ScienceDaily, 4 February 2013. <www.sciencedaily.com/releases/2013/02/130204094654.htm>.
Karolinska Institutet. (2013, February 4). High risk of cardiovascular diseases amongst Swedish-born and immigrant MS patients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/02/130204094654.htm
Karolinska Institutet. "High risk of cardiovascular diseases amongst Swedish-born and immigrant MS patients." ScienceDaily. www.sciencedaily.com/releases/2013/02/130204094654.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins